Relationship between Dietary Fatty Acid Intake with Nonalcoholic Fatty Liver Disease and Liver Fibrosis in People with HIV
Authors:
- Cristiane Fonseca de AlmeidaCACristiane Fonseca de Almeida
- Paula Simplicio da SilvaPSPaula Simplicio da Silva
- Claudia Santos de Aguiar CardosoCCClaudia Santos de Aguiar Cardoso
- Nathalia Gorni MoreiraNMNathalia Gorni Moreira
- Julliana Cormack AntunesJAJulliana Cormack Antunes
- Michelle Morata de AndradeMAMichelle Morata de Andrade
- Julio SilvaJSJulio Silva
- Marina Campos AraujoMAMarina Campos Araujo
- Wilza Arantes Ferreira PeresWilza Arantes Ferreira Peres
- Pedro Emmanuel Alvarenga Americano Do BrasilPBPedro Emmanuel Alvarenga Americano Do Brasil
- Ronaldo Ismerio MoreiraRMRonaldo Ismerio Moreira
- Sandra W. CardosoSCSandra W. Cardoso
Open Access
- 29 September 2021
- Vol. 13 (10) , 3462
Abstract
We aimed to evaluate the relationship between food intake of lipids with nonalcoholic fatty liver disease (NAFLD) and/or liver fibrosis in people living with HIV/AIDS (PLWHA). In this cross-sectional study, transient elastography was used to detect the presence of NAFLD and/or liver fibrosis. The dietary intake of fats and fatty acids (FA) were assessed by two 24 h dietary recalls (24-HDR) (n = 451). Multivariate logistic regression models were performed. Participants with higher intake of total fat were associated with higher odds for NAFLD compared to those with lower consumption [adjusted odds ratio (aOR) = 1.91 (95% confidence interval (95% CI) 1.06–3.44)]. Furthermore, participants with intermediate intake of n6-PUFA (n6-poly-unsaturated FA) and lauric FA had lower odds for NAFLD, respectively aOR = 0.54 (95% CI 0.3–0.98) and aOR = 0.42 (95% CI 0.22–0.78). Additionally, a higher intake of myristoleic FA (fourth quartile) was a significant protective factor for NAFLD [aOR = 0.56 (95% CI 0.32–0.99)]. Participants with higher intake of lauric FA [0.38 (95% CI 0.18–0.80)], myristic FA [0.38 (0.17–0.89)], palmitoleic FA [0.40 (0.19–0.82)] and oleic FA [0.35 (0.16–0.79)] had positively less odds of having liver fibrosis. On the other hand, higher intake of n-6 PUFA was significantly associated with fibrosis [aOR = 2.45 (95% CI 1.12–5.32)]. Dietary assessment of total fat and FA should be incorporated into HIV care as a tool for preventing NAFLD and fibrosis in PLWHA.Keywords
Funding Information
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (E-26/110.268/2014)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (405.211/2016-3, 407.410/2013-9 and 301.520/2014-3)
This publication has 53 references indexed in Scilit:
- The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver diseaseJournal of Hepatology, 2013
- Meta‐analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosisLiver International, 2013
- Changing Mortality Profile among HIV-Infected Patients in Rio de Janeiro, Brazil: Shifting from AIDS to Non-AIDS Related Conditions in the HAART EraPLOS ONE, 2013
- Alimentos mais consumidos no Brasil: Inquérito Nacional de Alimentação 2008-2009Revista de Saúde Pública, 2013
- Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastographyLiver International, 2012
- Dealing With Dietary Measurement Error in Nutritional Cohort StudiesJNCI: Journal of the National Cancer Institute, 2011
- Comparison between two race/skin color classifications in relation to health-related outcomes in BrazilInternational Journal for Equity in Health, 2011
- High-fat diet: A trigger of non-alcoholic steatohepatitis? Preliminary findings in obese subjectsNutrition, 2008
- Do We Know What Homeostasis Model Assessment Measures?Diabetes Care, 2007
- Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption‐IIAddiction, 1993